NewAmsterdam Pharma Co N.V.

8-K

NewAmsterdam Pharma Company N.V. and Louise Kooij agreed to end her employment as Chief Accounting Officer, effective August 31, 2026. A separation agreement includes 12 months salary, a bonus, and extended stock options vesting.

NewAmsterdam Pharma Co N.V. NAMS is headquartered in Narrden, Netherlands.

Source

Posted Apr 24, 2026, 8:33 PM UTC